Modafiendz
Wakefulness-promoting drug related to modafinil
From Wikipedia, the free encyclopedia
Modafiendz, also known as N-methyl-4,4-difluoromodafinil or as N-methylbisfluoromodafinil, is a wakefulness-promoting agent related to modafinil that was never marketed.[1][2][3] It is sold online and used non-medically as a nootropic (cognitive enhancer).[1][2][3]
Other namesN-Methyl-4,4-difluoromodafinil; Methyldifluoromodafinil; N-Methylbisfluoromodafinil; Bisfluoro-N-methylmodafinil; Methylflmodafinil
| Clinical data | |
|---|---|
| Other names | N-Methyl-4,4-difluoromodafinil; Methyldifluoromodafinil; N-Methylbisfluoromodafinil; Bisfluoro-N-methylmodafinil; Methylflmodafinil |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C16H15F2NO2S |
| Molar mass | 323.36 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Modafiendz is the bis-fluoro and N-methylated derivative of modafinil as well as the N-methyl analogue of flmodafinil (CRL-40,940; bisfluoromodafinil) and fladrafinil (CRL-40,941; bisfluoroadrafinil).[1][2]
Modafinil and its analogues have been found to act as selective dopamine reuptake inhibitors and this is thought to be involved in their wakefulness-promoting effects.[2]